Exhibit 99.1

Investors Contact: Allan Kells, (816) 201-2445, akells@cerner.com
Media Contact: Kay Hawes, (816) 201-1326, kay.hawes@cerner.com
Cerner’s Internet Home Page: www.cerner.com

Cerner Reports Third Quarter 2007 Results
Strong Earnings Growth and Margin Expansion

KANSAS CITY, Mo. — Oct. 18, 2007— Cerner Corp. (NASDAQ: CERN) today announced results for the 2007 third quarter that ended Sept. 29, delivering strong margin expansion and earnings growth.

Bookings in the third quarter 2007 were $356.7 million, which is up 1 percent from the third quarter of 2006. Year-to-date 2007 bookings were $1.10 billion, up 19 percent compared to $926.1 million of bookings in the same period of 2006. Year-to-date 2007 bookings exclude a $97.8 million booking in the second quarter of 2007 related to Cerner’s participation in the National Health Service (NHS) initiative to automate clinical processes and digitize medical records in England. Third quarter revenue increased 8 percent over the year-ago period to $372.9 million. Year-to-date 2007 revenue increased 13 percent to $1.13 billion.

On a Generally Accepted Accounting Principles (GAAP) basis, third quarter 2007 net earnings were $35.8 million, and diluted earnings per share were $0.43. Third quarter 2006 GAAP net earnings were $26.7 million, and diluted earnings per share were $0.33.

Adjusted (non-GAAP) Earnings

Adjusted third quarter 2007 net earnings were $38.4 million, which is 30 percent higher than the $29.6 million of adjusted net earnings in the third quarter of 2006. Adjusted diluted earnings per share were $0.46 in the third quarter of 2007 compared to $0.36 in the third quarter of 2006. Analysts’ consensus estimate for third quarter 2007 adjusted diluted earnings per share was $0.45.

Adjusted net earnings and diluted earnings per share exclude the impact of adopting Statement of Financial Accounting Standards (SFAS) No. 123R, Share-Based Payment,

which requires the expensing of stock options. The Company provides earnings with and without stock options expense because earnings excluding this expense are used by management along with GAAP results to analyze our business, make strategic decisions, and for management compensation purposes. Adjusted Net Earnings is not a recognized term under GAAP and should not be substituted for net earnings as a measure of the Company’s performance but instead should be utilized as a supplemental measure of financial performance in evaluating our business. Please see the accompanying schedule, titled ‘Reconciliation of Adjusted Net Earnings and Adjusted Diluted Earnings Per Share to GAAP Net Earnings and Diluted Earnings Per Share.’

Other Third Quarter Highlights:

• Cash collections of $402 million and operating cash flow of $80 million.

• Days sales outstanding of 89 days compared to 93 days in the year-ago quarter.

• Total revenue backlog of $3.12 billion, up 31 percent over the year-ago quarter. This is comprised of $2.59 billion of contract backlog and $528.9 million of support and maintenance backlog.

• 458 Cerner Millennium^Ò solution implementations were completed. Cerner has now turned on more than 7,200 Cerner Millennium solutions at more than 1,200 client facilities worldwide.

“We are pleased with our solid results in the third quarter,” said Neal Patterson, Cerner co-founder, chairman and chief executive officer. “Our focus on margin expansion is reflected in the very strong earnings growth we achieved this quarter.

“Our position as a leader in the global healthcare information technology industry was validated by record attendance of more than 6,700 people from 10 countries at Cerner’s Health Conference. Not only is this the largest client gathering in our company’s history, the event also included more than 100 exhibiting companies, making it a major industry conference as well.

“With an unmatched depth and breadth of solutions and services and a strategic footprint across acute care, ambulatory care, retail pharmacy, laboratory, pharmaceutical companies, and employers, Cerner is uniquely positioned to have a meaningful impact on the worldwide health economy,” Patterson said.

Future Period Guidance

The company expects revenue in the fourth quarter of 2007 to be approximately $405 million to $415 million. For the year 2007, Cerner expects revenue between $1.53 billion and $1.54 billion, or 11 to 12 percent over 2006.

Cerner expects adjusted diluted earnings per share before stock options expense in the fourth quarter to be between $0.50 and $0.51. This brings expectations for adjusted EPS before stock options expense for the full year 2007, to $1.73 to $1.74. The company expects SFAS No. 123R share-based compensation expense to reduce diluted earnings per share in the fourth quarter and full year by approximately $0.04 and $0.13, respectively, leading to expected diluted GAAP earnings per share between $0.46 and $0.47 for the fourth quarter and between $1.60 to $1.61 for the full year.

Cerner expects new business bookings in the fourth quarter of 2007 to be between $380 million and $400 million.

Earnings Conference Call

Cerner will host an earnings conference call to provide additional detail on third quarter results at 3:30 p.m. CT on Oct. 18. The dial-in number for the conference call is (617) 597-5396; the passcode is Cerner. The company recommends joining the call 15 minutes early for registration. The re-broadcast of the call will be available from 5:30 p.m. CDT, Oct. 18 through 11:59 p.m. CDT, Oct 21. The dial-in number for the re-broadcast is (617) 801-6888; the passcode is 74182820.

An audio webcast will be available both live and archived on Cerner’s Web site at www.cerner.com under the About Cerner section (click Investors, then Presentations and Webcasts). A copy of the script used during the call will also be available at the same section of www.cerner.com.

About Cerner

Cerner Corp. is taking the paper chart out of healthcare, eliminating error, variance and waste in the care process. With more than 6,000 clients worldwide, Cerner is the leading supplier of healthcare information technology. The following are trademarks of Cerner: Cerner, Cerner Millennium and Cerner’s logo. (NASDAQ: CERN), www.cerner.com

This release contains forward-looking statements that involve a number of risks and uncertainties. It is important to note that the Company’s performance, and actual results, financial condition or business could differ materially from those expressed in such forward-looking statements. The words “positioned,” “guidance” and “expects” or variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the possibility of product-related liabilities; potential claims for system errors and warranties; the possibility of interruption at our data centers or client support facilities; our proprietary technology may be subjected to infringement claims or may be infringed upon; risks associated with our global operations; our potential failure to effectively hedge against foreign currency exchange rate fluctuations; risks associated with the recruitment and retention of key personnel; risks related to third party suppliers; risks inherent with business acquisitions; changing political, economic and regulatory influences; government regulation; significant competition and market changes; variations in our quarterly operating results; and, potential inconsistencies in our sales forecasts compared to actual sales. Additional discussion of these and other factors affecting the Company’s business is contained in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time.

CERNER CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF EARNINGS

	Three Months						Three Months
	Ended			YTD			Ended			YTD
(In thousands, except per share data)	September 29, 2007 (1)			September 29, 2007 (1)			September 30, 2006 (2)			September 30, 2006 (2)
Revenue
System sales	$	115,272			368,238			125,180			356,394
Support, maintenance and services		249,086			729,186			210,265			612,068
Reimbursed travel		8,578			27,952			10,007			28,787
Total revenue		372,936			1,125,376			345,452			997,249
Margin
System sales		81,415			231,854			77,967			222,094
Support, maintenance and services		233,712			682,289			197,682			573,141
Total margin		315,127			914,143			275,649			795,235
Operating expenses
Sales and client service		164,380			487,382			144,198			425,599
Software development (Includes amortization of software development costs of $13,375,000, $40,063,000, $10,798,000 and $32,419,000, respectively.)		65,609			194,305			62,160			182,064
General and administrative		28,536			82,878			25,414			71,788
Total operating expenses		258,525			764,565			231,772			679,451
Operating earnings		56,602			149,578			43,877			115,784
Interest income		2,867			9,357			3,051			8,232
Interest expense		(3,057	)		(9,003	)		(3,064	)		(9,416	)
Other income		(402	)		(1,140	)		(33	)		2,026
Non-operating income (expense), net		(592	)		(786	)		(46	)		842
Earnings before income taxes		56,010			148,792			43,831			116,626
Income taxes		(20,169	)		(54,256	)		(17,103	)		(45,881	)
Net earnings	$	35,841			94,536			26,728			70,745
Basic earnings per share	$	0.45			1.19			0.34			0.91
Basic weighted average shares outstanding		79,634			79,190			77,844			77,508
Diluted earnings per share	$	0.43			1.14			0.33			0.87
Diluted weighted average shares outstanding		83,382			83,043			81,796			81,536

Note 1: Operating expenses for the three and nine months ended September 29, 2007 include share-based compensation expense. The impact of this expense for the quarter is a $2.5 million decrease, net of $1.6 million tax benefit, in net earnings and a decrease to diluted earnings per share of $.03. The allocation of share based compensation expense for the quarter is $2.3 million to Sales and client service, $.7 million to Software development and $1.1 million to General and administrative. The impact of this expense for the nine month period is a $7.6 million decrease, net of $4.7 million tax benefit, in net earnings and a decrease to diluted earnings per share of $.09. The allocation of share-based compensation expense for the nine month period is $7.3 million to Sales and client service, $2.3 million to Software development and $2.7 million to General and administrative.

Note 2: Operating expenses for the three and nine months ended September 30, 2006 include share based compensation expense. The impact of this expense for the quarter is a $2.9 million decrease, net of $1.8 million tax benefit, in net earnings and a decrease to diluted earnings per share of $.03. The allocation of share based compensation expense for the quarter is $2.8 million to Sales and client service, $1.1 million to Software development and $.8 million to General and administrative. The impact of this expense for the nine month period is a $8.9 million decrease, net of $5.5 million tax benefit, in net earnings and a decrease to diluted earnings per share of $.11. The allocation of share-based compensation expense for the nine month period is $8.6 million to Sales and client service, $3.3 million to Software development and $2.5 million to General and administrative.

CERNER CORPORATION
Reconciliation of Adjusted Net Earnings and Adjusted Diluted Earnings Per Share to
GAAP Net Earnings and Diluted Earnings Per Share¹

	Three Months Ended			Three Months Ended
Net Earnings	September 29, 2007			September 30, 2006
(In thousands)
Net earnings	$	35,841		$	26,728
Share-based compensation expense		4,094			4,688
Income tax benefit of share-based compensation		(1,566	)		(1,793	)
Adjusted net earnings (non-GAAP)	$	38,369		$	29,623
Diluted Earnings Per Share
Diluted earnings per share	$	0.43		$	0.33
Share-based compensation expense		0.03			0.03
Adjusted diluted earnings per share (non-GAAP)	$	0.46		$	0.36

Note 1: The presentation of Adjusted Net Earnings, a Non-GAAP financial measure, is not meant to be considered in isolation, as a substitute for, or superior to, Generally Accepted Accounting Principles (GAAP) results and investors should be aware that non-GAAP measures have inherent limitations and should be read only in conjunction with the Company’s consolidated financial statements prepared in accordance with GAAP. Adjusted Net Earnings may also be different from similar non-GAAP financial measures used by other companies and may not be comparable to similarly titled captions of other companies due to potential inconsistencies in the method of calculation. Adjusted Net Earnings includes adjustments to Net Earnings that the Company considers unique, infrequent or excluded by management in its analysis of the performance of the Company and management. The Company provides earnings with and without stock options expense because earnings excluding this expense are used by management along with GAAP results to analyze our business, make strategic decisions, and for management compensation purposes. The Company believes that Adjusted Net Earnings is important to enable investors to better understand and evaluate its ongoing operating results and allows for greater transparency in the review of its overall financial, operational and economic performance.

CERNER CORPORATION
CONSOLIDATED BALANCE SHEETS

	September 29,		December 30,
(In thousands)	2007		2006
Assets
Cash and cash equivalents	$	194,216		162,545
Short-term investments		114,211		146,239
Receivables, net		365,709		361,424
Inventory		12,861		18,084
Prepaid expenses and other		54,770		55,272
Deferred income taxes		2,183		2,423
Total current assets		743,950		745,987
Property and equipment, net		478,227		357,942
Software development costs, net		197,516		187,788
Goodwill, net		144,074		128,819
Intangible assets, net		50,437		54,428
Other assets		17,596		16,426
Total assets	$	1,631,800		1,491,390
Liabilities
Accounts payable	$	63,809		79,735
Current installments of long-term debt		14,032		20,242
Deferred revenue		92,785		93,699
Accrued payroll and tax withholdings		78,092		77,914
Other accrued expenses		17,380		29,741
Total current liabilities		266,098		301,331
Long-term debt		190,970		187,391
Deferred income taxes		76,245		68,693
Deferred revenue		16,233		14,557
Total liabilities		549,546		571,972
Minority owners’ equity interest in subsidiary		1,286		1,286
Stockholders’ Equity
Common stock		798		784
Additional paid-in capital		438,355		376,595
Retained earnings		634,689		540,153
Foreign currency translation adjustment		7,126		600
Total stockholders’ equity		1,080,968		918,132
Total liabilities and equity	$	1,631,800		1,491,390